Non-executive director Guo Huaqing increased his holdings in Keji Pharmaceutical (02171.HK) by 18,000 shares at a price of HK$14.52 per share.

According to the Guotong Financial APP, the latest data from the Hong Kong Stock Exchange shows that on December 18th, non-executive director Guo Huaqing increased his holdings of China Resources Medication (02171.HK) by 18,000 shares, with a price of 14.52 Hong Kong dollars per share, totaling approximately 261,400 Hong Kong dollars. After the increase, the latest number of shares held is approximately 225 million shares, with a shareholding percentage of 39.01%.